{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:22:46Z","timestamp":1740147766267,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T00:00:00Z","timestamp":1551744000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s11739-019-02060-0","type":"journal-article","created":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T03:04:23Z","timestamp":1551755063000},"page":"1083-1090","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure"],"prefix":"10.1007","volume":"14","author":[{"given":"Edoardo","family":"Bertero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Miceli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Lorenzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manrico","family":"Balbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Ghigliotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Chiarella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Brunelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Viazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Pontremoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Canepa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7167-7287","authenticated-orcid":false,"given":"Pietro","family":"Ameri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,5]]},"reference":[{"issue":"23","key":"2060_CR1","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1056\/nejm198706043162301","volume":"316","author":"CONSENSUS Trial Study Group","year":"1987","unstructured":"CONSENSUS Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure. Results of the cooperative north scandinavian enalapril survival study (CONSENSUS). N Engl J Med 316(23):1429\u20131435. \n                    https:\/\/doi.org\/10.1056\/nejm198706043162301","journal-title":"N Engl J Med"},{"issue":"5","key":"2060_CR2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1056\/NEJM199108013250501","volume":"325","author":"SOLVD Investigators","year":"1991","unstructured":"Investigators SOLVD, Yusuf S, Pitt B, Davis CE, Hood WB, Cohn JN (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325(5):293\u2013302. \n                    https:\/\/doi.org\/10.1056\/NEJM199108013250501","journal-title":"N Engl J Med"},{"issue":"9386","key":"2060_CR3","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/S0140-6736(03)14284-5","volume":"362","author":"CB Granger","year":"2003","unstructured":"Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, Ostergren J, Pfeffer MA, Swedberg K, CHARM Investigators and Committees (2003) Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-alternative trial. Lancet 362(9386):772\u2013776. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(03)14284-5","journal-title":"Lancet"},{"issue":"9386","key":"2060_CR4","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S0140-6736(03)14283-3","volume":"362","author":"JJ McMurray","year":"2003","unstructured":"McMurray JJ, Ostergren J, Swedberg K, Granger CB, Held P, Michelson EL, Olofsson B, Yusuf S, Pfeffer MA, CHARM Investigators and Committees (2003) Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-added trial. Lancet 362(9386):767\u2013771. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(03)14283-3","journal-title":"Lancet"},{"issue":"27","key":"2060_CR5","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, ESC Scientific Document Group (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37(27):2129\u20132200. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehw128","journal-title":"Eur Heart J"},{"issue":"11","key":"2060_CR6","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1016\/j.jacc.2004.01.041","volume":"43","author":"J Butler","year":"2004","unstructured":"Butler J, Arbogast PG, Daugherty J, Jain MK, Ray WA, Griffin MR (2004) Outpatient utilization of angiotensin-converting enzyme inhibitors among heart failure patients after hospital discharge. J Am Coll Cardiol 43(11):2036\u20132043. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2004.01.041","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2060_CR7","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1161\/01.CIR.0000138934.28340.ED","volume":"110","author":"FA Masoudi","year":"2004","unstructured":"Masoudi FA, Rathore SS, Wang Y, Havranek EP, Curtis JP, Foody JM, Krumholz HM (2004) National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction. Circulation 110(6):724\u2013731. \n                    https:\/\/doi.org\/10.1161\/01.CIR.0000138934.28340.ED","journal-title":"Circulation"},{"issue":"2","key":"2060_CR8","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ijcard.2007.10.009","volume":"125","author":"S Setoguchi","year":"2008","unstructured":"Setoguchi S, Levin R, Winkelmayer WC (2008) Long-term trends of angiotensin-converting enzyme inhibitor and angiotensin-receptor blocker use after heart failure hospitalization in community-dwelling seniors. Int J Cardiol 125(2):172\u2013177. \n                    https:\/\/doi.org\/10.1016\/j.ijcard.2007.10.009","journal-title":"Int J Cardiol"},{"issue":"34","key":"2060_CR9","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1093\/eurheartj\/ehv268","volume":"36","author":"M Edner","year":"2015","unstructured":"Edner M, Benson L, Dahlstrom U, Lund LH (2015) Association between renin\u2013angiotensin system antagonist use and mortality in heart failure with severe renal insufficiency: a prospective propensity score-matched cohort study. Eur Heart J 36(34):2318\u20132326. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehv268","journal-title":"Eur Heart J"},{"key":"2060_CR10","doi-asserted-by":"publisher","first-page":"204800401773447","DOI":"10.1177\/2048004017734476","volume":"6","author":"U Tayal","year":"2017","unstructured":"Tayal U, Prasad SK (2017) Myocardial remodelling and recovery in dilated cardiomyopathy. JRSM Cardiovasc Dis 6:2048004017734476. \n                    https:\/\/doi.org\/10.1177\/2048004017734476","journal-title":"JRSM Cardiovasc Dis"},{"issue":"12","key":"2060_CR11","doi-asserted-by":"publisher","first-page":"e0168349","DOI":"10.1371\/journal.pone.0168349","volume":"11","author":"O Huttin","year":"2016","unstructured":"Huttin O, Coiro S, Selton-Suty C, Juilliere Y, Donal E, Magne J, Sadoul N, Zannad F, Rossignol P, Girerd N (2016) Prediction of left ventricular remodeling after a myocardial infarction: role of myocardial deformation\u2014a systematic review and meta-analysis. PLoS ONE 11(12):e0168349. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0168349","journal-title":"PLoS ONE"},{"issue":"11","key":"2060_CR12","doi-asserted-by":"publisher","first-page":"647","DOI":"10.4330\/wjc.v8.i11.647","volume":"8","author":"L Gigli","year":"2016","unstructured":"Gigli L, Ameri P, Secco G, De Blasi G, Miceli R, Lorenzoni A, Torre F, Chiarella F, Brunelli C, Canepa M (2016) Clinical characteristics and prognostic impact of atrial fibrillation in patients with chronic heart failure. World J Cardiol 8(11):647\u2013656. \n                    https:\/\/doi.org\/10.4330\/wjc.v8.i11.647","journal-title":"World J Cardiol"},{"issue":"1","key":"2060_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/ejhf.13","volume":"16","author":"H Clark","year":"2014","unstructured":"Clark H, Krum H, Hopper I (2014) Worsening renal function during renin\u2013angiotensin\u2013aldosterone system inhibitor initiation and long-term outcomes in patients with left ventricular systolic dysfunction. Eur J Heart Fail 16(1):41\u201348. \n                    https:\/\/doi.org\/10.1002\/ejhf.13","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"2060_CR14","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1161\/01.CIR.0000116764.53225.A9","volume":"109","author":"FA McAlister","year":"2004","unstructured":"McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW (2004) Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 109(8):1004\u20131009. \n                    https:\/\/doi.org\/10.1161\/01.CIR.0000116764.53225.A9","journal-title":"Circulation"},{"issue":"6","key":"2060_CR15","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.ahj.2007.03.017","volume":"153","author":"AK Berger","year":"2007","unstructured":"Berger AK, Duval S, Manske C, Vazquez G, Barber C, Miller L, Luepker RV (2007) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease. Am Heart J 153(6):1064\u20131073. \n                    https:\/\/doi.org\/10.1016\/j.ahj.2007.03.017","journal-title":"Am Heart J"},{"issue":"8","key":"2060_CR16","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.jchf.2016.03.002","volume":"4","author":"A Pandey","year":"2016","unstructured":"Pandey A, Golwala H, DeVore AD, Lu D, Madden G, Bhatt DL, Schulte PJ, Heidenreich PA, Yancy CW, Hernandez AF, Fonarow GC (2016) Trends in the use of guideline-directed therapies among dialysis patients hospitalized with systolic heart failure: findings from the american heart association get with the guidelines-heart failure program. JACC Heart Fail 4(8):649\u2013661. \n                    https:\/\/doi.org\/10.1016\/j.jchf.2016.03.002","journal-title":"JACC Heart Fail"},{"issue":"7","key":"2060_CR17","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/S0735-1097(03)00947-1","volume":"42","author":"JB Braunstein","year":"2003","unstructured":"Braunstein JB, Anderson GF, Gerstenblith G, Weller W, Niefeld M, Herbert R, Wu AW (2003) Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol 42(7):1226\u20131233","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2060_CR18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/ejhf.23","volume":"16","author":"M B\u00f6hm","year":"2014","unstructured":"B\u00f6hm M, Pogue J, Kindermann I, Poss J, Koon T, Yusuf S (2014) Effect of comorbidities on outcomes and angiotensin converting enzyme inhibitor effects in patients with predominantly left ventricular dysfunction and heart failure. Eur J Heart Fail 16(3):325\u2013333. \n                    https:\/\/doi.org\/10.1002\/ejhf.23","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"2060_CR19","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.jacc.2013.04.088","volume":"62","author":"T Hasin","year":"2013","unstructured":"Hasin T, Gerber Y, McNallan SM, Weston SA, Kushwaha SS, Nelson TJ, Cerhan JR, Roger VL (2013) Patients with heart failure have an increased risk of incident cancer. J Am Coll Cardiol 62(10):881\u2013886. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2013.04.088","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2060_CR20","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/ejhf.472","volume":"18","author":"A Banke","year":"2016","unstructured":"Banke A, Schou M, Videbaek L, Moller JE, Torp-Pedersen C, Gustafsson F, Dahl JS, Kober L, Hildebrandt PR, Gislason GH (2016) Incidence of cancer in patients with chronic heart failure: a long-term follow-up study. Eur J Heart Fail 18(3):260\u2013266. \n                    https:\/\/doi.org\/10.1002\/ejhf.472","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"2060_CR21","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/ejhf.1165","volume":"20","author":"P Ameri","year":"2018","unstructured":"Ameri P, Canepa M, Anker MS, Belenkov Y, Bergler-Klein J, Cohen-Solal A, Farmakis D, Lopez-Fernandez T, Lainscak M, Pudil R, Ruschitska F, Seferovic P, Filippatos G, Coats A, Suter T, Von Haehling S, Ciardiello F, de Boer RA, Lyon AR, Tocchetti CG, Heart Failure Association Cardio-Oncology Study Group of the European Society of Cardiology (2018) Cancer diagnosis in patients with heart failure: epidemiology, clinical implications and gaps in knowledge. Eur J Heart Fail 20(5):879\u2013887. \n                    https:\/\/doi.org\/10.1002\/ejhf.1165","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"2060_CR22","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.ahj.2010.12.009","volume":"161","author":"S Ather","year":"2011","unstructured":"Ather S, Chan W, Chillar A, Aguilar D, Pritchett AM, Ramasubbu K, Wehrens XH, Deswal A, Bozkurt B (2011) Association of systolic blood pressure with mortality in patients with heart failure with reduced ejection fraction: a complex relationship. Am Heart J 161(3):567\u2013573. \n                    https:\/\/doi.org\/10.1016\/j.ahj.2010.12.009","journal-title":"Am Heart J"},{"issue":"4","key":"2060_CR23","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.ahj.2004.06.030","volume":"149","author":"A Ahmed","year":"2005","unstructured":"Ahmed A, Centor RM, Weaver MT, Perry GJ (2005) A propensity score analysis of the impact of angiotensin-converting enzyme inhibitors on long-term survival of older adults with heart failure and perceived contraindications. Am Heart J 149(4):737\u2013743. \n                    https:\/\/doi.org\/10.1016\/j.ahj.2004.06.030","journal-title":"Am Heart J"},{"issue":"11","key":"2060_CR24","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJ McMurray","year":"2014","unstructured":"McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, Investigators P-H, Committees (2014) Angiotensin\u2013neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371(11):993\u20131004. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1409077","journal-title":"N Engl J Med"},{"issue":"15","key":"2060_CR25","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1093\/eurheartj\/ehw570","volume":"38","author":"M B\u00f6hm","year":"2017","unstructured":"B\u00f6hm M, Young R, Jhund PS, Solomon SD, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Swedberg K, Zile MR, Packer M, McMurray JJV (2017) Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril\/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF. Eur Heart J 38(15):1132\u20131143. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehw570","journal-title":"Eur Heart J"},{"issue":"6","key":"2060_CR26","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jchf.2018.02.004","volume":"6","author":"K Damman","year":"2018","unstructured":"Damman K, Gori M, Claggett B, Jhund PS, Senni M, Lefkowitz MP, Prescott MF, Shi VC, Rouleau JL, Swedberg K, Zile MR, Packer M, Desai AS, Solomon SD, McMurray JJV (2018) Renal effects and associated outcomes during angiotensin\u2013neprilysin inhibition in heart failure. JACC Heart Fail 6(6):489\u2013498. \n                    https:\/\/doi.org\/10.1016\/j.jchf.2018.02.004","journal-title":"JACC Heart Fail"},{"key":"2060_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1182","author":"G Savarese","year":"2018","unstructured":"Savarese G, Carrero JJ, Pitt B, Anker SD, Rosano GMC, Dahlstrom U, Lund LH (2018) Factors associated with underuse of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: an analysis of 11 215 patients from the Swedish Heart Failure Registry. Eur J Heart Fail. \n                    https:\/\/doi.org\/10.1002\/ejhf.1182","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"2060_CR28","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/ejhf.807","volume":"19","author":"K Tsuji","year":"2017","unstructured":"Tsuji K, Sakata Y, Nochioka K, Miura M, Yamauchi T, Onose T, Abe R, Oikawa T, Kasahara S, Sato M, Shiroto T, Takahashi J, Miyata S, Shimokawa H, CHART-2 Investigators (2017) Characterization of heart failure patients with mid-range left ventricular ejection fraction-a report from the CHART-2 study. Eur J Heart Fail 19(10):1258\u20131269. \n                    https:\/\/doi.org\/10.1002\/ejhf.807","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"2060_CR29","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/S0002-9149(97)00060-X","volume":"79","author":"BA Bart","year":"1997","unstructured":"Bart BA, Gattis WA, Diem SJ, O\u2019Connor CM (1997) Reasons for underuse of angiotensin-converting enzyme inhibitors in patients with heart failure and left ventricular dysfunction. Am J Cardiol 79(8):1118\u20131120","journal-title":"Am J Cardiol"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-019-02060-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11739-019-02060-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-019-02060-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T19:06:35Z","timestamp":1583262395000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11739-019-02060-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,5]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["2060"],"URL":"https:\/\/doi.org\/10.1007\/s11739-019-02060-0","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"type":"print","value":"1828-0447"},{"type":"electronic","value":"1970-9366"}],"subject":[],"published":{"date-parts":[[2019,3,5]]},"assertion":[{"value":"1 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the local Ethics Committee and conforms to the ethical guidelines of the 1974 Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statements on human and animal rights"}},{"value":"Informed consent was obtained from all participants in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}